A prospective longitudinal study of cognitive and psychosocial functioning in pediatric hematopoietic stem cell transplant (HSCT) patients was conducted on three occasions: pre-HSCT, 1 year post-HSCT, and 2 years post-HSCT. In contrast to the previous hypothesis that cognitive declines would occur as a result of HSCT treatment, it was hypothesized that (1) global cognitive functioning (IQ scores), as well as specific areas would remain stable over time; (2) pre-transplant functioning would be predictive of later functioning; and (3) age would be negatively related to cognitive functioning. Based on previous research it was further hypothesized: that (4) while declines in psychosocial functioning might be seen at 1 year, functioning would improve by 2 years. 153 children and adolescents were evaluated pre-HSCT and at 1 year, with 2 year data available for 74 children. Advances in pediatric hematopoietic stem cell transplantation (HSCT) have resulted in increased survival and greater attention to long-term effects of treatment. Mortality remains relatively high in this population, however, and accumulation of data from a sufficient number of patients who survive this treatment involves many years. As a result, our understanding of the cognitive and behavioral Correspondence: MJ Kupst,
functioning of these children and adolescents post-treatment is still emerging. Until recently, research in this area was limited to clinical descriptions, individual case studies, or a single-occasion assessment of a small number of children and adolescents.
Due to the lack of sufficient data from pediatric GSCT patients, the suspected impact of treatment on cognitive functioning has been extrapolated from other diseases and treatments, ie cranial irradiation and chemotherapy for acute lymphocytic leukemia (ALL) or CNS tumors, [1] [2] [3] [4] [5] [6] the effects of which were demonstrated to be dose-and agerelated. It has been hypothesized that pre-HSCT conditioning regimens, including total body irradiation (TBI) have a detrimental effect on children undergoing HSCT. However, results of cross-sectional studies have shown mixed results, with some 7-9 indicating significant cognitive and developmental delays, and others 10, 11 indicating general normal development. The lack of baseline data and relatively small sample sizes probably contribute to the variability in results. With some exceptions, longitudinal studies of neurocognitive functioning have shown few significant changes in global IQ scores (Full Scale, Verbal, or Performance IQs). Table 1 shows a comparison of the results of these studies. [12] [13] [14] [15] [16] [17] [18] Potential correlates of cognitive outcome (age at HSCT, dose of TBI, diagnosis, gender, and treatment regimen) have been examined in several studies, 13, 17, 18 with age 7, 15, 18 and pre-HSCT functioning 17 being the strongest correlates. Based on the results of the most recent longitudinal studies, it was expected that global IQ, as well as scores on specific neurocognitive abilities, would remain relatively Table 1 Studies of cognitive ability at baseline and 1 year post-HSCT
Study Sample (n) Results
Pot-Mees 12 
23
No significant changes a Kramer et al 13 
22
No significant changes b Phipps et al 21 
25
No significant changes Cool 15 
41
PIQ increased; VIQ decreased Kramer et al 16 
67
Significant decline in IQ stable pre-HSCT to 2 years post-HSCT. The present study tested the hypothesis: (1) that treatment with hematopoietic stem cell transplant does not result in significant decreases in neurocognitive outcomes in children and adolescents. It was further hypothesized: (2) that pre-HSCT cognitive functioning is predictive of later cognitive functioning (at 1 and 2 years post-HSCT) and (3) that age is positively correlated with later cognitive functioning. Cognitive functioning is an important outcome of HSCT, but in terms of quality of life, it is really an intermediate endpoint. Given the multiple stressors on the developing child and adolescent undergoing hematopoietic stem cell transplant, some effects on adjustment and adaptation might be expected. Some studies 19, 20 initially found symptoms of post-traumatic stress with continued improvement 2 or more years after transplant. On the other hand, general behavioral adjustment tended to be stable or to improve by 1 year post-HSCT. 14, 21, 22 The area most affected appeared to be social functioning. 21, 23, 24 However, results of longitudinal studies indicated a return to functioning similar to that before transplant at 2 years post-HSCT. 21, 23 In terms of correlates of adjustment 2 or more years post-HSCT, 25 time since transplant (longer, better) and maternal distress (higher, worse) were significant predictors, but neither selfworth nor social acceptance were related to adjustment. As in cognitive functioning, pre-transplant adjustment appears to have a significant influence on both adjustment and quality of life. 26 In general, the demands of HSCT with isolation, absence from school, physical changes and other personal and family stresses can also lead to decreases in functioning. While longitudinal studies are relatively few in pediatric HSCT, longitudinal studies of coping and adjustment in pediatric cancer patients 27, 28 have demonstrated the significant resilience of these children despite lengthy intensive treatment and concurrent stresses. Based on these results and those of previous HSCT studies, some difficulties in adjustment might be expected in the first year post-HSCT, with a return to more normal functioning at 2 years post-HSCT.
We believe that this study represents the largest number of children and adolescents studied prospectively from pre-HSCT to 2 years post-HSCT. We also believe that it provides the most comprehensive analysis to date of the variables related to cognitive and psychosocial functioning in a longitudinal sample.
Materials and methods

Participants
As part of the treatment protocol for HSCT, psychological evaluations were conducted with all potential candidates for HSCT during the pre-transplant work up. Over approximately a 10-year period (September 1988-July 1999), 377 children and adolescents were tested prior to hematopoietic stem cell transplantation. Of these, 187 (49%) died within the first year after HSCT. Thirty-seven (9%) were lost to follow-up, most (24) of these patients lived out of state and did not return to the center for follow-up medical evaluations. Other reasons for lack of follow-up were: parental or patient refusal (5), patients too sick to conduct evaluation (1), eligible patients who had been scheduled but failed the appointment and were rescheduled (3), or no response to request for follow-up (4) . A total of 153 children and adolescents completed the pre-HSCT and 1 year post-HSCT evaluation. Of these, 16 (10%) children died prior to the 2-year point. Thirty-four lived far from the transplant center, and did not return to the center for 2-year evaluations. Eighteen were not yet at the 2-year point and were to be scheduled, one was too sick, eight were adults who decided not to have testing done, and six could not be contacted. Two-year post-HSCT data were available for 74 infants, children and adolescents.
Demographic characteristics
The mean age at the time of hematopoietic stem cell transplant was 9 years 6 months (s.d. = 5 years 3 months). Nineteen were under 3 years of age. With regard to gender, 85 (55.6%) were male and 68 (44.4%) were female. Based on the Hollingshead 29 categories, socioeconomic status was as follows: high (n = 20; 13.1%); upper middle (n = 49; 32.0%), middle (n = 52; 34.0%); lower middle (n = 28; 18.3%) and low (n = 4; 2.6%). With regard to ethnicity, 132 (86.3%) were Caucasian, 12 (7.8%) were AfricanAmerican, five (3.3%) were Hispanic, and four (2.6) were of mixed ethnic background. These demographics are reflective of the population served at this institution.
Disease/treatment characteristics
Diagnoses at the time of HSCT for participants in this in this study are as follows: ALL: n = 62 (41%); ANLL: n = 22 (14%); aplastic anemia: n = 22 (14%); CML: n = 13 (8%); myelodysplastic syndrome: n = 7 (5%); immune deficiency disorders: n = 6 (4%); Ewing sarcoma: n = 5 (3%); other anemias: n = 5 (3%); neuroblastoma: n = 4 (3%); lymphomas: n = 4 (3%); and other (lymphoproliferative disease, undifferentiated hematologic malignancy, amegakaryocytic thrombocytopenia): n = 3 (2%).
With regard to type of transplant, over half were matched unrelated (n = 79; 51.6%), followed by related matched (n = 53; 35%), autologous (n = 11; 7%), and haploidentical (n = 10; 6%).
With regard to pre-HSCT treatment, most of the participants (117; 77%) had received prior chemotherapy, and 18 (12%) had received prior radiation therapy. Most of the children (142; 93%) received total body irradiation. All of the children received a preparative regimen that included chemotherapy. 30 Most (129 or 84%) of the children received the standard protocol: AraC, cyclophosphamide and TBI. Other regimens were as follows: immune deficiency diseases and sickle cell anemia (6 or 4%): busulfan, cyclophosphamide and ATG; aplastic anemia, matched related: cyclophosphamide and ATG (5 or 3%); solid tumors (autologous): VP16, melphalan and TBI (5 or 3%); ANLL, amegakaryocytic thrombocyopenia: busulfan, cyclophosphamide (3 or 2%) . Those with other diseases (5 or 3%) received different combinations of these chemotherapeutic agents.
In order to quantify one type of acuity of medical problems during transplant, children were given ratings of both acute and chronic graft-versus-host disease. These ratings were based upon standard criteria. 31, 32 Acute GVHD, ratings were: none (35%), low (42%), moderate (19%), and severe (4%). Chronic GVHD ratings were: none (52%), limited (37%), and extensive (5%), or not evaluable (6%).
Procedure
Participants provided written informed consent at the time of the pre-transplant evaluation. The initial assessment was usually done within the first 2 weeks prior to transplant, as the child was undergoing the pre-HSCT medical work-up (mean time before HSCT = 12 days; s.d. = 1.7 months; range = 9 months (transplant was delayed) to 3 days prior to HSCT). The rationale and procedure for testing was described to the family prior to testing by the pediatric hematopoietic stem cell transplant psychologist and/or psychology associate (4th year clinical psychology graduate students with supervised practicum experience in pediatric psychology). In addition to the interview, parents were asked to complete a Background Information Questionnaire and the Child Behavior Checklist. 33 With the exception of infants and very young children (less than 3 years of age), children and adolescents were tested without parents present. They were given the age-appropriate cognitive and academic tests, as well as a brief interview about current functioning in school, family, and social areas and their attitudes and feelings about imminent hematopoietic stem cell transplant. Initial findings were shared with the patients and parents, with a written report given to families usually within a week.
The psychologist and psychology associate provided continued contacts where needed throughout the inpatient and outpatient phases of treatment. At 1 and 2 years post-HSCT, the testing was repeated in a similar fashion. Where indicated or requested, and with parental permission, school contacts were made to assist in reintegration and special needs.
Measures
Cognitive testing: In order to measure overall cognitive functioning, the instruments selected were as follows: ages 0-3: Bayley Scales of Infant Development 34, 35 and Vineland Scales of Adaptive Behavior; 36 ages 3-6: Wechsler Preschool and Primary Scale of Intelligence-Revised (WPPSI-R) 37 or, in some early administrations, McCarthy Scales of Children's Abilities; 38 ages 6-16: Wechsler Intelligence Scale for Children-Revised (WISC-R) 39 or Wechsler Intelligence Scale for Children-Third Edition (WISC-III); 40 ages 17+: Wechsler Adult Intelligence ScaleRevised (WAIS-R). 41 In order to permit the most valid comparisons, within the same age category, children were administered the same form of the test. For example, even though the WISC-III was used with new participants after 1994, those who had been tested with the WISC-R previously received the WISC-R at subsequent administrations (n = 29). However, one of the primary difficulties in assessing children and adolescents is that different instruBone Marrow Transplantation ments are used at different ages. Some studies have combined the standard scores from these different instruments, which would enable use of testing data for all participants. Despite the loss in sample size, we believed that a more valid analysis compared only the Wechsler scales over time, which will constitute the primary focus of the cognitive analysis of this paper.
Of the 153 children and adolescents who completed both initial and 1-year testing, 101 completed Wechsler scales at the initial assessment (an additional 30 were tested but had insufficient data to compute IQ scores either due to medical condition or behavioral considerations). Twentytwo of these were very young children who completed Bayley Scales and Vineland Scales, or in early years of data collection, McCarthy Scales. At the 1 year point, 99 completed the Wechsler scales (two had died). At the 2-year point, 70 completed the Wechsler scales and four completed the Bayley and Vineland Scales. Of the remaining 25, 10 had died, and 15 lived out of state and did not return for the 2-year follow-up evaluations.
Although some previous studies had used abbreviated forms of the Wechsler scales, we believed that it was important to include subscales that assess areas that have been shown to be affected by CNS treatment, eg arithmetic, short-term memory, visual-motor integration, psychomotor speed, as well as the Freedom from Distractibility Factor. In addition, the Reading and Arithmetic subtests of the Wide Range Achievement Test (WRAT) 42 were also administered.
Psychosocial functioning: Parents completed the Child Behavior Checklist 33 on all three occasions. This scale has good psychometric properties and is the most commonly used scale of behavior problems and social competence in pediatric psychology research. Global T-scores were obtained for Behavior Problems (Internalizing and Externalizing Problems) and Social Competence (Activities, School, and Social areas). T-scores have a mean of 50 and standard deviation of 10. Pre-HSCT functioning information was obtained through the interview and Background Information Questionnaire (history of previous psychosocial problems, involvement with the mental health providers, other family stresses). Subsequent data were obtained through the open-ended questions of the CBCL and interviews with child/adolescent and family.
Results
Cognitive functioning
IQ scores over time: Where possible, eg age over 3, the Wechsler scales were administered, as the IQ and subscale scores are most directly comparable. To examine change in Full Scale IQ from the pre-HSCT assessment to the 1 year assessment, a paired samples t-test was conducted (n = 99; mean 1 = 101.00; s.d. = 15.04; mean 2 = 101.65; s.d. = 15.64). No significant change was noted (t = Ϫ0.72; df = 98; P = 0.47). Table 2 shows the pre-HSCT, 1 and 2-year post-HSCT IQ means and standard deviations for all participants at all data points.
To test within-subject changes over 2 years, repeated measures analyses of variance were performed with SES as a covariate (n = 52). Table 3 shows the means and standard deviations. No significant changes were noted in Full Scale, Verbal, or Performance IQ scores at 1 or 2 years.
In comparing the participants in the repeated measures analyses with all participants, the means in the repeated measures analyses appeared slightly higher. However, ttests comparing the total sample with the repeated measures sample were done and no significant differences were found for FSIQ, VIQ, or PIQ for any of the measurement points.
To test for the differential effects of attrition, IQ, demographic (SES, gender, age), diagnostic (diagnosis) treatment (pre-and post-HSCT chemotherapy, radiation), and personal data (existence of prior psychosocial problems, school performance, family stresses), as well as previous IQ and CBCL scores, were compared across three groups: all participants who began the study, those with two assessments, and those with all three assessments. No significant differences were found in any of the comparisons.
In addition, a longitudinal sign test was conducted based on similar analyses that have been conducted with neuropsychological longitudinal studies that have missing data and where ordered alternatives can be specified. 43 This test is powerful and robust and does not utilize moment assumptions or equality of the distributions, ie (H 0 : P = 0.5; H 1 : P у 0.05). It allows for the use of all cases that have at least two data points (in the cognitive data, n = 100). The results indicate that there was no significant difference across occasions (P = 0.69 (S у 48 given H 0 : P = 0.5).
Interrelationships among variables:
No significant correlations were found between IQ at all three points with age at time of transplant, previous chemotherapy, TBI, or acuity of problems, eg acute or chronic graft-versus-host disease. Socioeconomic status was correlated (higher SES (lower Hollingshead score), higher IQ) with all three Full Scale IQ scores (Pre-HSCT: r = Ϫ0.34, df = 96, P Ͻ 0.001; 1 year: r = Ϫ0.25, df = 103, P Ͻ 0.01; 2 years: r = Ϫ0.39, df = 61, P Ͻ 0.002). In addition, having a previously diagnosed learning disability at the time of HSCT was related to several cognitive outcomes: pre-HSCT (t = 2.46, df = 54; P Ͻ 0.02), One (t = 2.64; df = 59; P Ͻ 0.01) and 2 years post-HSCT Full Scale IQ (t = 2.18; df = 42; P Ͻ 0.03).
Full scale IQ scores at all three occasions were strongly intercorrelated: pre-HSCT with 1 year: r = 0.85; P Ͻ 0.0001 and with 2 years: r = 0.86, P Ͻ 0.0001); 1 year with 2 years: r = 0.93, P Ͻ 0.0001).
With the 2 year full scale IQ as criterion variable, a hierarchical step-wise multiple regression analysis was computed (see Table 4 ).
Only variables that had been significantly correlated (P Ͻ 0.005) with the 2 year full scale IQ score were entered. These included SES and the pre-HSCT and 1-year full scale IQ scores. This model accounted for 84% of the total variance (adjusted r 2 = 0.82; F = 36.01; P Ͻ 0.0001) in 2 year full scale IQ. The strongest predictor of the 2 year full scale IQ score was the 1-year full scale IQ score which accounted for 82% of the total variance. The pre-HSCT full scale IQ only contributed 2.3% to the total variance, and SES only contributed less than 1%. Other models that included learning disability and age at time of HSCT did not provide additional contributions to the total variance.
Specific cognitive areas:
Wechsler subscale means were examined over time. One year (mean = 8.95; s.d. = 3.34) and 2 year (mean = 9.22; s.d. = 3.88) subscale means were not significantly different from the pre-HSCT means (mean = 9.28; s.d. = 2.93) and were all within the average range, with variability similar to that of normative data. The only area that was significantly different from normative data was mental arithmetic. Pre-HSCT arithmetic was significantly lower than norms (where the mean = 10 and s.d. = 3): t = Ϫ2.34; df = 89, P Ͻ 0.02. Similarly, the 1 year Table 4 Multiple regression -Predictors of Full Scale IQ at 2 years mean, while not significantly decreased pre-HSCT, was significantly lower than norms. (t = Ϫ3.19; df = 102; P Ͻ 0.002). In addition, reading and arithmetic achievement scores (WRAT3) are also examined. (A standard score of 100 is the average, with a standard deviation of 15). Word reading was within the average range, with no significant changes over time. However, written arithmetic was significantly lower than normative data at all three occasions (t = Ϫ2.79, df = 58, P Ͻ 0.007; t = Ϫ2.57; df = 65; P Ͻ 0.01; t = Ϫ3.115, df = 47; P Ͻ 0.003). Arithmetic scores did not change significantly over time, and were not significantly related to prior treatment, diagnosis, age at transplant. However, having been diagnosed with a learning disability prior to HSCT was significantly related to arithmetic scores (WISC arithmetic scores) at pre-HSCT (t = 2.87; df = 53; P Ͻ 0.006) and 1 year (t = 3.52; df = 58; P Ͻ 0.001). Thus, pre-HSCT arithmetic ability was a significant correlate of later ability. In addition, the Freedom from Distractibility factor is frequently assessed as it involves areas typically affected by CNS treatment. In this study, all means were within the normal range and there were no significant changes over time.
Cognitive functioning of infants and young children:
Sixtyone infants and young children 3 years of age and under were evaluated during this time. Of these, 38 died before the 1 year follow-up evaluation. Seven were lost to followup, and evaluable data were available for 16 children thus far (70% of the possible infant and young child sample). The scores from different developmental scales are not directly comparable, but the standard scores allow for categorization according to level of functioning (eg 80-89, low average range; 90-109 = average range; 110-119 above average range). With regard to change, at the 1-year point, level of developmental/cognitive functioning increased (n = 4), decreased (n = 4) and remained stable (n = 5). At the 2-year point, of the eight children who had evaluations, levels increased (n = 3), decreased (n = 4) and one remained stable. Thus, there was no consistent pattern of cognitive functioning in the serial evaluations. These results are similar to those found by Simms et al. 17 As in that study and in other longitudinal studies, the number of infants and very young children who survived beyond the first year is still small and data collection is continuing. Table 5 shows the means and standard deviations over time for the social (Social Competence and behavioral (Total Behavior)) domains of the Child Behavior Checklist (CBCL) for all participants. All behavior means were within the normal range. in the clinical range (4%, n = 72) at the pre-HSCT assessment. At 1 year post-HSCT, six were in the clinical range (7.6% of the total with Social Competence scores, n = 78). At 2 years, none were in the clinical range). Thus, the prevalence of behavior problems in this sample was quite low.
Psychosocial functioning
To examine change over time, repeated measures analyses of variance were conducted for both Total Behavior and Social Competence (with age as a covariate) scores. Results (see Table 6 ) indicated no significant changes over time for Total Behavior (F = 1.25; P = 0.293) or for Social Competence (F = 0.745; P = 0.645).
In order to control for attrition effects, pre-HSCT and 1 year scores were compared as were demographic, diagnostic and treatment variables, across three groups: all participants who began the study, those with two assessments, and those with all three assessments. No significant differences were found.
As in the cognitive analyses, longitudinal sign tests were conducted to assess change over time in both the Behavior Problem and Social Competence means. For the Total Behavior means, (n = 95), the results indicate that there was no significant difference across occasions (P = 0.72; (S у 39 given H 0 : P = 0.5). Similarly, for the Social Com- petence means, (n = 95), no significant difference was found across occasions (P = 0.54; S у 53 given H 0 : P = 0.5).
With regard to correlates of social and behavioral functioning, pre-HSCT scores were significantly correlated with 1-year scores (r = 0.55; df = 87; P Ͻ 0.0001) and with 2-year scores r = 0.64, df = 39; P Ͻ 0.0001). One-year scores were also correlated with 2 year scores (r = 0.71, df = 38, P Ͻ 0.0001). Behavior scores were not significantly related to age, gender, socioeconomic status, diagnosis, or type of treatment. However, total Social Competence scores were significantly correlated with age, with older children having higher Social Competence scores at one year (r = 0.30, df = 76, P Ͻ 0.007), but not at 2 years post-HSCT.
The relationship between cognitive and social/behavioral functioning was also examined and significant correlations were found between Full Scale IQ and Social Competence scores pre-HSCT (r = 0.53, df = 53; P Ͻ 0.0001), at 1 (r = 0.42, df = 55; P Ͻ 0.001) and 2 years post-HSCT (r = 0.56; df = 43; P Ͻ 0.0001). No significant relationships were found between IQ scores and behavioral scores. As in the IQ analyses, having a previous diagnosis of a learning disability was related to Social Competence. At 1 and 2 years post-HSCT, the learning disabled group was found to be significantly lower in Social Competence (t = Ϫ2.18, df = 60; P Ͻ 0.03) and (t = Ϫ2.72, df = 34, P Ͻ 0.01), as would be expected (Social Competence scores include academic functioning, eg special classes).
Psychological intervention (by HSCT psychology and social work staff, in addition to the standard initial assessments and discussions) during and after the transplant was also examined as a potential correlate of psychosocial functioning (it was also examined with regard to cognitive functioning as well). No significant differences were found between those who had received intervention (n = 55) and those who had not (n = 98).
In order to examine predictors of Social Competence scores, hierarchical step-wise multiple regression analyses were conducted on the 2-year Social Competence scores (see Table 7 ).
Only variables that correlated Ͼ0.005 were permitted. Thus, the model included the pre-HSCT Social Competence, 1 year HSCT Social Competence, and Full Scale IQ scores, and accounted for 57% (adjusted r 2 = 48%) of the total variance (F = 9.77; P Ͻ 0.006). Pre-HSCT Social Competence was the strongest predictor of Social Competence at 2 years post-HSCT, accounting for 36% of the total variance. Other predictors were Social Competence at 1 year (an additional 9%) and Full Scale IQ (12%). In order to examine the predictors of Total Behavior at 2 years post-HSCT, hierarchical step-wise regression analyses were performed (see Table 8 ).
Using the criterion of a significance level of 0.005 correlations, only the pre-HSCT and 1 year post-HSCT Total Behavior scores were entered, accounting for 55% of the total variance (adjusted r 2 = 0.52; F = 19.90, P Ͻ 0.0001). One year Total Behavior accounted for 44% of the variance with pre-HSCT accounting for an additional 11%.
Discussion
The hypothesis of stability in global cognitive functioning was supported in this study. IQ index scores tended to remain stable, as did Wechsler scale subtest scores. These findings are similar to those of the previous longitudinal studies with relatively large samples. 14, 17, 18 However, they differ from Kramer et al's 16 longitudinal study that found a significant decline in IQ between baseline and 1 year. While the overall results are similar to those of the Phipps et al, 18 the latter study suggested that young age at time of transplant was a risk factor for later cognitive declines. The differences in findings may be partially explained by the differences in samples. Kramer et al's 16 sample was significantly younger (mean age was 45 months, while in the present study, mean age was 114 months), and, therefore, more vulnerable to the effects of treatment. A relationship between young age and later problems was not found in this study, but this finding may be due to a lower number of young children in the sample, as well as a difference in the time of measurement. As suggested by some recent research, 45 cognitive declines may not appear for several years after treatment, indicating the need for longer followup of these children and adolescents.
The only exception to the finding of stable cognitive functioning was in the area of lower arithmetic scores, which has been found, in studies of ALL and CNS treatment, to be a frequent late effect. 44 Many of the children in this study were diagnosed with ALL and had undergone intensive systemic and intrathecal chemotherapy, which has been identified as a risk factor for neurocognitive problems in children with ALL. [1] [2] [3] [4] [5] [6] 44 Mental arithmetic requires both attention and short-term memory, also abilities that can be affected by CNS treatment.
With regard to correlates of cognitive and psychosocial outcomes, no relationship was found with gender, type of transplant, type of treatment, or acuity of problems. It should be mentioned that most of the sample underwent TBI, so that it was difficult to have a powerful comparison with those who did not receive TBI. On the other hand, the relatively low prevalence of cognitive problems might suggest that the typical doses of TBI used in HSCT, in contrast with those in CNS tumors and ALL, may not result in the serious neurocognitive late effects seen in those children. In addition, there were 18 children who had cranial radiation prior to HSCT, followed by TBI, and no significant declines in functioning were noted in this subgroup. In most analyses, age at HSCT was not a significant predictor, but it did correlate with Social Competence at 1 year, indicating that older children may return to school and social activities more quickly than do younger children. As is often found in studies of IQ, both generally 45 and in chronic illness, 46 socioeconomic status was related to IQ scores. However, in this study, the strongest predictor of cognitive and psychosocial functioning was pre-HSCT functioning. Children and adolescents with higher cognitive functioning tended to fare better in terms of cognitive, academic and social functioning. Most of the sample demonstrated adequate cognitive and psychosocial functioning, and, from a resilience standpoint, factors that tended to strengthen functioning included: pre-HSCT cognitive and academic ability, pre-HSCT behavioral and social functioning, relatively higher socioeconomic status, and older age at 1 year (for Social Competence scores).
The developmental results in infants and young children were mixed, as some were doing well and others having declined by 1 year. As in previous studies, this study was limited by the low number of very young children who survived for at least 1 year. It will be necessary to continue collecting data in this age group to be able to determine the impact of treatment, and indicates the need for multisite studies to obtain data more quickly. In addition, as cognitive problems may not appear for several years, 44 it will be necessary to follow the whole cohort in this study beyond 2 years, ideally for 5 years post HSCT.
The relative lack of psychosocial problems, even when multiple indicators of functioning were employed, supports the hypothesis that most of these children and adolescents adjust relatively well. Given results of previous epidemiological studies that estimate 15-30% of children with chronic illnesses had significant behavioral problems, 46 these children and adolescents appear to be functioning above what would be expected. These results are similar to those of other longitudinal and long-term follow-up studies, 27, 28, [48] [49] [50] which demonstrated a lack of serious psychological problems in pediatric cancer patients. It also points to the need for a non-pathological model focusing on the factors that promote resilience despite multiple severe stressors involved in the transplant process. It should also be noted that in this setting, as in most large pediatric HSCT centers, there is usually a psychosocial team that provides standard psychosocial assessment and care. Thus, the results are probably generalizable to such settings and may not be applicable to the psychosocial functioning of all HSCT patients and families.
One consideration that should be mentioned for both the cognitive and psychosocial assessments is that, while global functioning may be adequate, there may be subtle or subclinical indicators that require more specific measurement. In the case of IQ, Wechsler subtests measuring specific abilities were used, but specific measures of memory, attention, and processing speed were not included. However,
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Simms et al's 17 study, using additional neuropsychological tests of specific abilities (e.g. visual-motor integration, memory) found similar results. Additionally, Phipps et al's 18 found stability in IQ and other neuropsychological test scores, with the exception of a marginal decline in visual-motor integration at 3 years post-HSCT. In the case of behavioral data, the CBCL is the usual instrument for measuring adjustment in children and adolescents, but it is possible that it may not be as sensitive to change as other types of measures, eg behavioral observations. In this study, interview, chart and paper and pencil data provided additional information on psychosocial functioning in school, as well as psychosocial intervention. However, specific observational and behavioral data during the transplant process would be helpful in describing how children and adolescents cope with hospitalization and clinic visits in the acute phase of treatment, and whether early behaviors are predictive of later behaviors.
Perhaps the main criticism involves the attrition over time, and that differential attrition may be a confounding factor, eg that those with poorer functioning tended to drop out. However, those who completed all three assessments did not differ in any of the demographic, disease, treatment, cognitive and behavioral functioning data from those who only completed earlier assessments. A question may also be raised about the representativeness of this study sample in terms of the general pediatric bone marrow transplant population. However, the scores obtained in this study resemble those of the samples in the CHOP and St Jude studies, which would suggest a representative sample, at least of those who were assessed in this way.
Despite these limitations, we believe that these findings shed light on the importance of examining the effects of HSCT treatment on cognitive functioning. We believe that it is equally important to study the way HSCT impacts behavioral, social and emotional functioning over time. The importance of early assessment cannot be underestimated (those with previous learning difficulties and psychosocial problems were found to be most at risk for later problems in functioning), as well as the need to follow these patients prospectively. We are continuing the study with the goal of assessing these participants further in the long-term follow-up program at this institution.
